Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies.

Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies.

Item
http://www.wikidata.org/entity/Q41147581
Targeted Therapy in Systemic SclerosisRiociguat: a soluble guanylate cyclase stimulator for the treatment of pulmonary hypertension.Early Observations on the Use of Riociguat in a Large, Metropolitan Pulmonary Arterial Hypertension/Chronic Thromboembolic Pulmonary Hypertension Treatment Center.Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures PerspectivesRiociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2.Fibrogenesis, novel lessons from animal models.Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy.Treatment of systemic sclerosis: is there any hope for the future?Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis.Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis.Use of biologics and other novel therapies for the treatment of systemic sclerosis.
P2860

Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies.

Item
http://www.wikidata.org/entity/Q41147581
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Stimulators of soluble guanyla ...... osis of different aetiologies.
@en
type
label
Stimulators of soluble guanyla ...... osis of different aetiologies.
@en
prefLabel
Stimulators of soluble guanyla ...... osis of different aetiologies.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P698
P356
P1433
P1476
Stimulators of soluble guanyla ...... osis of different aetiologies.
@en
P2093
P2860
P304
P31
P356
10.1136/ANNRHEUMDIS-2014-206809
P407
P433
P478
P50
P577
P698